Vaccination with human alphapapillomavirus-derived L2 multimer protects against human betapapillomavirus challenge, including in epidermodysplasia verruciformis model mice.
- DOI
- 10.1016/j.virol.2022.08.006
- Published
- 2022 Oct
- Container
- Virology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.virol.2022.08.006,
title = {Vaccination with human alphapapillomavirus-derived L2 multimer protects against human betapapillomavirus challenge, including in epidermodysplasia verruciformis model mice.},
author = {Olczak P and Wong M and Tsai HL and Wang H and Kirnbauer R and Griffith AJ and Lambert PF and Roden R},
year = {2022},
journal = {Virology},
doi = {10.1016/j.virol.2022.08.006},
url = {https://doi.org/10.1016/j.virol.2022.08.006}
}RIS
TY - JOUR TI - Vaccination with human alphapapillomavirus-derived L2 multimer protects against human betapapillomavirus challenge, including in epidermodysplasia verruciformis model mice. AU - Olczak P AU - Wong M AU - Tsai HL AU - Wang H AU - Kirnbauer R AU - Griffith AJ AU - Lambert PF AU - Roden R PY - 2022 JO - Virology DO - 10.1016/j.virol.2022.08.006 UR - https://doi.org/10.1016/j.virol.2022.08.006 ER -
APA
P, O., M, W., HL, T., H, W., R, K., AJ, G., PF, L., & R, R. (2022). Vaccination with human alphapapillomavirus-derived L2 multimer protects against human betapapillomavirus challenge, including in epidermodysplasia verruciformis model mice.. Virology. https://doi.org/10.1016/j.virol.2022.08.006
Source records
- pubmed · retrieved 2026-09-26T13:10:17.474Z
- europe-pmc · retrieved 2026-09-26T13:10:17.468Z